Events and Conferences

Contact Veristat Now

Request A Proposal

Contact Us

2024 ASCO Annual Meeting

May 3, 2024

Meet the Veristat team at ASCO,  May 31st to June 4th in Chicago  

Read More

Swiss Biotech Day

March 19, 2024

Meet Veristat in Basel at the Swiss Biotech Day, 22-23 April 2024 

Read More

Cell & Gene Meeting on the Med 2024, an ARM Conference

March 11, 2024

Meet Veristat in Rome at the Meeting on the Med Conference 2024, 9-11 April 2024 

Read More

Webinar | Planning for a Successful Initial IND and Moving Beyond

August 31, 2023

Sponsored Webcast: Planning for a Successful Initial IND and Moving Beyond: Regulatory CMC Considerations for Biotherapeutics and Cell and Gene Therapies


Tuesday, 19 Sep 2023 | 11:00 AM Eastern Time (US & Canada)


Read More

Webinar | Single-Arm Studies for Use as a Registrational Study in Oncology

May 10, 2023

Veristat and  CITELINE  hosted a  webinar on the topic: Single-Arm Studies for Use as a Registrational Study in Oncology                        


Read More

Webinar  | Impact of New Medical Device EU Regulation (MDR) on the Development of Drug-Device Combination Products

May 10, 2023

Veristat and  TOPRA hosted a webinar on the topic: Impact of New EU Regulations on the Development of Medical Devices and Drug Combination Products                             


Read More

Marcus Evans Evolution Summit May 2023

April 20, 2023

Meet with Shaheen Limbada, EVP Innovation and Strategy at the Evolution Summit



Read More

ASGCT Annual Meeting 2023

April 18, 2023

Veristat’s John Balser, PhD., will be presenting in the scientific symposium  



Read More

DIA Global Annual Meeting 2023

April 3, 2023

Attend our Innovation Theater Presentation on Decentralized Clinical Trials



Read More

Updated Webinar  | Future Trends on European Regulations on Medicines

March 9, 2023


Veristat and TOPRA hosted  a new updated content webinar on the topic:  Future Trends on European Regulations on Medicines                            

What  You Will Learn

The European Commission announced on 25 November 2020 the adoption of the new Pharmaceutical Strategy for Europe. It is an approach intended to ensure strong, fair competitivity and green industry, fostering patient access to innovative and affordable medicines. It will ensure an autonomous and robust supply chain and a stronger EU voice at the global level by promoting a high level of quality, efficacy and safety standards. 


Read More